DAGVX | VIVIX | DAGVX / VIVIX | |
Total Expense Ratio | 0.93 | 0.04 | 2,325% |
Annual Report Gross Expense Ratio | 0.95 | 0.04 | 2,375% |
Fund Existence | 30 years | 27 years | - |
Gain YTD | 9.569 | 6.533 | 146% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.89B | 196B | 5% |
Annual Yield % from dividends | 0.86 | 2.19 | 39% |
Returns for 1 year | 5.78 | 7.91 | 73% |
Returns for 3 years | 16.78 | 25.93 | 65% |
Returns for 5 years | 47.77 | 68.54 | 70% |
Returns for 10 years | 23.24 | 114.61 | 20% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IAUM | 33.30 | 0.03 | +0.09% |
iShares® Gold Trust Micro | |||
NCZ | 13.21 | 0.01 | +0.08% |
Virtus Convertible & Income Fund II | |||
VYLD | 25.82 | N/A | N/A |
Inverse Vix Short-Term Futures Etns Due March 22, 2045 | |||
DDIV | 38.67 | -0.12 | -0.31% |
First Trust Dorsey Wright Momt & Div ETF | |||
MIDE | 31.34 | -0.22 | -0.70% |
Xtrackers S&P MidCap 400 Scrd & Scrn ETF |